Pay in 4 interest-free payments of $31.25 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
These Bis-benzimides were originally developed by Hoechst AG
Smiles: CN1N=NC2=C(N=CN2C1=O)C(N)=O
smooth muscle and
It was isolated in 1949 from the microbial organism Aspergillus fumigatus
GAP-134 - CAS# 943134-39-2 e Rb2 a potent antioxidant with anticancer activities These Bis-benzimides were originally developedDanegaptide, also known as GAP 134 and ZP1609, is an orally active small molecule gap junction modifier for the treatment of atrial fibrillation. Danegaptide mproves conduction and reduces atrial fibrillation flutter in the canine sterile pericarditis model. Danegaptide prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia reperfusion injury in open chest dogs. Product information CAS Number: 943134 39 2
US$ 20.00
US$ 25.00
US$ 125.00
US$ 109.50
US$ 176.00
US$ 25.00
US$ 28.00
US$ 145.50
US$ 60.00
US$ 180.99
US$ 199.00